Clinical Trials Directory

Trials / Completed

CompletedNCT05857176

Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.

Assessment of Safety and Satisfaction Toward COVID-19 Vaccines: A Cross-sectional Study.

Status
Completed
Phase
Study type
Observational
Enrollment
508 (actual)
Sponsor
Damanhour University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a cross-sectional, web-based online survey done with the use of a Google Form-questionnaire to gather information from the general public regarding their knowledge, satisfaction, and tolerability about the COVID-19 vaccine.

Detailed description

* A cross-sectional study was conducted. The subjects participating in the study are residents in Egypt. * An online questionnaire, designed on Google Forms, was written in Arabic language and delivered to participants via social media (primarily Facebook, WhatsApp and Linkedin). * The questionnaire comprised two categories of inquiries. The first is demographic data of the subject. The second is questions about COVID-19 vaccine-related data, such as whether had taken the vaccine or not, the type of vaccine administered, side effects encountered from the vaccine , if got enough information regarding the vaccine and where obtain the vaccine information from and if reluctant to taking the vaccine and the reasons for hesitancy. All participants were permitted to terminate the survey at any time of the study.

Conditions

Interventions

TypeNameDescription
OTHERCOVID-19 Vaccine questionnaireAn online questionnaire, designed on Google Forms, was written in Arabic language and delivered to participants via social media (primarily Facebook, WhatsApp and Linkedin).

Timeline

Start date
2021-12-15
Primary completion
2022-02-01
Completion
2022-02-10
First posted
2023-05-12
Last updated
2023-05-23

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05857176. Inclusion in this directory is not an endorsement.